# Assessment of the Therapeutic Utility of hMG-HP

> **NCT01330784** · — · COMPLETED · sponsor: **Ferring Pharmaceuticals** · enrollment: 61 (actual)

## Conditions studied

- Sterility

## Interventions

- **DRUG:** hMG-HP

## Key facts

- **NCT ID:** NCT01330784
- **Lead sponsor:** Ferring Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2006-10
- **Primary completion:** 2008-07
- **Final completion:** 2008-09
- **Target enrollment:** 61 (ACTUAL)
- **Last updated:** 2011-04-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01330784

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01330784, "Assessment of the Therapeutic Utility of hMG-HP". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01330784. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*